Seer Seer Q1 Revenues Fall on Decline in Grant Revenue The Redwood City, California-based proteomics firm posted revenues of $62,000, down from $177,000 in the year-ago period due a decline in grant revenue. Seer Prices $110.5M Follow-on Stock Offering The company will use the proceeds to commercialize and further develop its Proteograph Product Suite and for other R&D and corporate purposes. Seer Plans Offering of 3.5M Shares of Common Stock The company said that it will use the proceeds to commercialize its Proteograph Product Suite but did not say when the offering will take place. Breaking News Sophia Genetics Raises $234M in IPO, Eyes Additional Partnerships Canadian Government, Partners Commit C$59.8M to Natural Resources, Environmental Genomics Projects People in the News: New Appointments at Element Biosciences, Sema4, OriCiro Genomcs, More New Products Posted to GenomeWeb: Thermo Fisher, Paradigm4, Applied Cells, More In Brief This Week: Caribou Biosciences, AnchorDx, Neogen, Microbiome Insights, More Cytek Biosciences Prices $200M Initial Public Offering The Scan Shape of Them All According to BBC News, researchers have developed a protein structure database that includes much of the human proteome. For Flu and More The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza. To Boost Women China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post. Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.